The effects of cholinesterase inhibitors are concentration dependent, increasing the susceptibility of women, elderly individuals, and patients with chronic kidney disease to adverse effects such as the cardiac arrhythmias caused by cholinesterase inhibitors (Kho et al., 2021; Kobayashi et al., 2023). Here, BCHE is linked to chronic obstructive pulmonary disease.